# Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia

> **NCT00934258** · — · AVAILABLE · sponsor: **National Taiwan University Hospital**

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** rosuvastatin,fenofibrate
- **GENETIC:** CYP2C9, UGT1A1, UGT1A3, OATP2, BCRP

## Key facts

- **NCT ID:** NCT00934258
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00934258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00934258, "Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00934258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*